Cellphmed
Lausanne
About Cellphmed
Cellphmed developed proprietary tools to decipher unexplored regions of the genome, encompassing millions of uncharted RNA biomarkers. They serves virology, machine learning, AI, RNA, RNA biomarkers, biomarkers, transposable elements, transposable transcriptome, TES, and oncology.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $9.8K
- Last round: Grant (Jan 2017)
- Website: cellphmed.bio
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/cellphmed-2433438 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.